Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia [0.03%]
肉毒杆菌毒素治疗良性前列腺增生所致的下尿路症状
Alberto A Antunes,Miguel Srougi,Rafael F Coelho et al.
Alberto A Antunes et al.
Botulinum toxin (BTX) is the most potent biological toxin used for the treatment of urologic conditions. During the last 3 years, the use of BTX has been extended to the treatment of symptomatic benign prostatic hyperplasia, however, the ac...
Jonathan L Wright,Michael P Porter
Jonathan L Wright
Health-related quality of life (HRQOL) in patients with bladder cancer is important, because radical cystectomy and urinary diversion significantly affect urinary and sexual function, and lead to associated sex-specific morbidity. This arti...
Giacomo Novara,Antonio Galfano,Vincenzo De Marco et al.
Giacomo Novara et al.
Squamous cell carcinoma (SCC) of the penis is an uncommon disease in the US and Europe. Without treatment, patients with penile SCC usually die within 2 years after diagnosis of the primary lesion, because of uncontrollable locoregional dis...
Monish Aron,Georges-Pascal Haber,Inderbir S Gill
Monish Aron
John S Lam,Alberto Breda,Peter G Schulam
John S Lam
Mohammed A Rafey,Michael S Lipkowitz
Mohammed A Rafey
Is initial or delayed nephrectomy the optimal treatment for nonmetastatic Wilms' tumor? [0.03%]
初始性肾切除术和延迟性肾切除术哪个是未转移的威斯库姆瘤的最佳治疗方法？
Michael P La Quaglia
Michael P La Quaglia
Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer? [0.03%]
左旋肉碱预防低危表浅膀胱癌复发的有效性随机临床试验
Harry W Herr
Harry W Herr
Clarifying the indications for adjuvant chemotherapy in muscle-invasive bladder cancer [0.03%]
肌侵袭性膀胱癌辅助化疗指征的确定
Peter Albers
Peter Albers
Behfar Ehdaie,Dan Theodorescu
Behfar Ehdaie